Evidence map›Paper›PMID 28662105›Full record

ArticlePloS one2017

Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.

Azumi Ishizaki, Vuong Thi Tran, Cuong Hung Nguyen, Tomoaki Tanimoto, Huyen Thi Thanh Hoang, Hung Viet Pham, Chung Thi Thu Phan, Xiuqiong Bi, Thuc Van Pham, Hiroshi Ichimura

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Azumi IshizakiDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Vuong Thi TranHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Cuong Hung NguyenHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Tomoaki TanimotoDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Huyen Thi Thanh HoangHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Hung Viet PhamDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Chung Thi Thu PhanDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Xiuqiong BiDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Thuc Van PhamHai Phong University of Medicine and Pharmacy, Hai Phong, Viet Nam.
Hiroshi IchimuraDepartment of Viral infection and International Health, Graduate school of Medical Sciences, Kanazawa University, Kanazawa, Japan.ORCID http://orcid.org/0000-0003-4478-1964
Kanazawa University · JPHai phong University Of Medicine and Pharmacy · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported a significant reduction in the prevalence of human immunodeficiency virus type 1 (HIV) from 2007 to 2012 in people who inject drugs (PWID; 35.9% to 18.5%, p < 0.001) and female sex workers (FSW; 23.1% to 9.8%, p < 0.05), but not in blood donors (BD) or pregnant women, in Haiphong, Vietnam. Our aim in the present study was to assess trends in the prevalence of infection with hepatitis B and C viruses (HBV and HCV, respectively). We also investigated the coinfection rates of HBV and HCV with HIV in the same groups. Between 2007 and 2012, HBV prevalence was significantly decreased in BD (18.1% vs. 9.0%, p = 0.007) and slightly decreased in FSW (11.0% vs. 3.9%, p = 0.21), but not in PWID (10.7% vs. 11.1%, p = 0.84). HCV prevalence was significantly decreased in PWID (62.1% in 2007 vs. 42.7% in 2008, p < 0.0001), but it had rebounded to 58.4% in 2012 (2008 vs. 2012, p < 0.0001). HCV prevalence also increased in FSW: 28.6% in 2007 and 2009 vs. 35.3% in 2012; however, this difference was not significant (2007 vs. 2012, p = 0.41). Rates of coinfection with HBV and HCV among HIV-infected PWID and FSW did not change significantly during the study period. Our findings suggest that the current harm reduction programs designed to prevent HIV transmission in PWID and FSW may be insufficient to prevent the transmission of hepatitis viruses, particularly HCV, in Haiphong, Vietnam. New approaches, such as the introduction of catch-up HBV vaccination to vulnerable adult populations and the introduction of HCV treatment as prevention, should be considered to reduce morbidity and mortality due to HIV and hepatitis virus coinfection in Vietnam.

Indexed as

AdultFemaleHepatitis BHepatitis CHIV InfectionsHumansMalePrevalenceSex WorkSubstance Abuse, IntravenousVietnamYoung Adult

Identifiers

PMID28662105
PMCPMC5491323
OpenAlexW2733705438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.